Invention Grant
- Patent Title: Stable formulations of amylin and its analogues
- Patent Title (中): 胰岛淀粉样多肽及其类似物的稳定制剂
-
Application No.: US12676970Application Date: 2008-09-11
-
Publication No.: US08404645B2Publication Date: 2013-03-26
- Inventor: Morten Schlein
- Applicant: Morten Schlein
- Applicant Address: DK Bagsvaerd
- Assignee: Novo Nordisk AS
- Current Assignee: Novo Nordisk AS
- Current Assignee Address: DK Bagsvaerd
- Agent Jianjie Hu
- Priority: EP07116066 20070911
- International Application: PCT/EP2008/062035 WO 20080911
- International Announcement: WO2009/034118 WO 20090319
- Main IPC: A61K38/16
- IPC: A61K38/16
Abstract:
The invention relates to a soluble pharmaceutical composition for parenteral administration, which comprises an amylin peptide and an anionic surfactant, and methods for treatment of hyperglycemia.
Public/Granted literature
- US20100240587A1 STABLE FORMULATIONS OF AMYLIN AND ITS ANALOGUES Public/Granted day:2010-09-23
Information query
IPC分类:
